BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

543 related articles for article (PubMed ID: 11157643)

  • 1. Heparin and low-molecular-weight heparin: mechanisms of action, pharmacokinetics, dosing, monitoring, efficacy, and safety.
    Hirsh J; Warkentin TE; Shaughnessy SG; Anand SS; Halperin JL; Raschke R; Granger C; Ohman EM; Dalen JE
    Chest; 2001 Jan; 119(1 Suppl):64S-94S. PubMed ID: 11157643
    [No Abstract]   [Full Text] [Related]  

  • 2. Mechanism of action and pharmacology of unfractionated heparin.
    Hirsh J; Anand SS; Halperin JL; Fuster V
    Arterioscler Thromb Vasc Biol; 2001 Jul; 21(7):1094-6. PubMed ID: 11451734
    [No Abstract]   [Full Text] [Related]  

  • 3. Heparin and low-molecular-weight heparin: mechanisms of action, pharmacokinetics, dosing considerations, monitoring, efficacy, and safety.
    Hirsh J; Warkentin TE; Raschke R; Granger C; Ohman EM; Dalen JE
    Chest; 1998 Nov; 114(5 Suppl):489S-510S. PubMed ID: 9822059
    [No Abstract]   [Full Text] [Related]  

  • 4. The present and future of heparin, low molecular weight heparins, pentasaccharide, and hirudin for venous thromboembolism and acute coronary syndromes.
    Haas S
    Semin Vasc Med; 2003 May; 3(2):139-46. PubMed ID: 15199477
    [TBL] [Abstract][Full Text] [Related]  

  • 5. New-generation anticoagulants: the low molecular weight heparins.
    Hovanessian HC
    Ann Emerg Med; 1999 Dec; 34(6):768-79. PubMed ID: 10577408
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Venous thromboembolism: a guide to prevention and treatment.
    Crowther M; McCourt K
    Nurse Pract; 2005 Aug; 30(8):26-9, 32-4, 39-43; quiz 44-5. PubMed ID: 16094200
    [No Abstract]   [Full Text] [Related]  

  • 7. Venous thromboembolism and pregnancy.
    Andres RL; Miles A
    Obstet Gynecol Clin North Am; 2001 Sep; 28(3):613-30. PubMed ID: 11512505
    [TBL] [Abstract][Full Text] [Related]  

  • 8. AHA Scientific Statement: Guide to anticoagulant therapy: heparin: a statement for healthcare professionals from the American Heart Association.
    Hirsh J; Anand SS; Halperin JL; Fuster V;
    Arterioscler Thromb Vasc Biol; 2001 Jul; 21(7):E9-9. PubMed ID: 11451763
    [No Abstract]   [Full Text] [Related]  

  • 9. The role of low-molecular-weight heparins in the management of unstable angina and non-ST-segment elevation myocardial infarction.
    Cohen M
    J Thromb Thrombolysis; 2001 Apr; 11(2):171-4. PubMed ID: 11406733
    [No Abstract]   [Full Text] [Related]  

  • 10. Low molecular weight heparins: are they interchangeable? No.
    Nenci GG
    J Thromb Haemost; 2003 Jan; 1(1):12-3. PubMed ID: 12871532
    [No Abstract]   [Full Text] [Related]  

  • 11. [New medical anticoagulants].
    Choussat R; Montalescot G
    Rev Mal Respir; 1999 Nov; 16(5 Pt 2):985-95. PubMed ID: 10907447
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Therapeutic equivalency of low-molecular-weight heparins.
    McCart GM; Kayser SR
    Ann Pharmacother; 2002 Jun; 36(6):1042-57. PubMed ID: 12022908
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [State of the art: low-molecular-weight heparin and beyond].
    Cimminiello C; Casali G; Vitali L
    Minerva Cardioangiol; 2000 Dec; 48(12 Suppl 1):61-5. PubMed ID: 11253343
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Deep venous thrombosis: outpatient therapy with low-molecular-weight heparin.
    Tapson VF
    Manag Care; 1999 Dec; 8 Suppl():2-6. PubMed ID: 11729399
    [No Abstract]   [Full Text] [Related]  

  • 15. Anticoagulants in coronary artery disease.
    Lee LV
    Cardiol Clin; 2008 Nov; 26(4):615-28. PubMed ID: 18929235
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Low-molecular-weight herapin.
    Whang PG; Lieberman JR
    J Am Acad Orthop Surg; 2002; 10(5):299-302. PubMed ID: 12374480
    [No Abstract]   [Full Text] [Related]  

  • 17. Heparin and low-molecular-weight heparin.
    Gray E; Mulloy B; Barrowcliffe TW
    Thromb Haemost; 2008 May; 99(5):807-18. PubMed ID: 18449410
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Low molecular weight heparins: are they superior to unfractionated heparins to prevent and to treat deep vein thrombosis?
    Boneu B
    Thromb Res; 2000 Oct; 100(2):V113-20. PubMed ID: 11053624
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Low-molecular-weight heparin and other antithrombotic agents in the setting of a primarily medical treatment of unstable coronary artery disease.
    Verheugt FW
    Haemostasis; 2000; 30 Suppl 2():122-7; discussion 106-7. PubMed ID: 11251355
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Think of HIT when thrombosis follows heparin.
    Warkentin TE
    Chest; 2006 Sep; 130(3):631-2. PubMed ID: 16963651
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 28.